People affected by migraine reluctant to see their doctor and keep their condition private at work due to fear of judgement, says study. The survey, conducted by the European Migraine & Headache Alliance (EMHA), found that the impact of migraine stigma was at the centre of their daily lives February 7, 2024. A new survey […]
Stigma survey press release Read More »
Migraine & Stigma Survey 2023 In 2023, the EMHA conducted a comprehensive pan-European digital survey answered by 4.210 people across 17 countries. In order to examinate the origins of stigma surrounding migraine, its impact on patients, and their need for better understanding and support. The survey covers various topics such as patients’ ease in sharing
Migraine and mental health in women: Addressing the challenge On September 21st, the EMHA presented with Gamian Europe the results on their study Migraine and mental health in women: Addressing the challenge. This report seeks to highlight the comorbidity between women affected by severe migraine attacks and mental health conditions. Over 15% of the European
Migraine and mental health in women Read More »
Put Patients First in Headache Treatment: Stephani Sutherland, PhD, is a neuroscientist, yogi, and freelance writer in Southern California. Migraine and other severe headache disorders affect about a billion people worldwide each year, but awareness of these conditions is insufficient, and sufferers are often stigmatized by healthcare providers and by society in general. As a
Put Patients First in Headache Treatment Read More »
This year Migraine Day of Action will be held on September 12th and EMHA has created an initiative called #MigraineBrighterFuture What is #MigraineBrighterFuture? It´s an online campaign which involves patients all around the globe and everybody who would like to help on raising awareness about Migraine. How to participate? September 12th participants will need to upload
Migraine Day of Action Read More »
Novartis marks a new era for migraine patients with the EU approval of Aimovig®, a first-of-its- kind treatment specifically designed for migraine prevention Jul 30, 2018 New Aimovig Medication Approved Novartis announced today that the European Commission (EC) approved Aimovig® (erenumab) for the prevention of migraine in adults experiencing four or more migraine days per month.
New Aimovig Medication Approved Read More »
Patients claim their right to participate in Decision about their Health Patients have the right to participate in making decisions about their health, either through patient organizations in public policies that affect them or through the sharing of information and consensus with their doctor, for example, about what treatment to follow. This is one of
European Patients’ Rights Day, TODAY, April 18 Read More »
IAPO is organising a Patient solidarity Day the 2nd of December! If you’re taking part in a Patient Solidarity Day activity, upload your photos from activities and events to help raise awareness and inspire others and at the same time stand the chance of being next year’s feature photo. For more information go in to IAPO´s website
Patient Solidarity Day 2017 is on December 2 Read More »
Let me set the scene of motherhood with migraines : a Monday evening in late January. My husband had been working like a dog for over a week and I had barely seen him in days. The kids were just getting over their latest in a series of winter illnesses and they were post-sick exhausted
One Tough Challenge: Motherhood with Migraines Read More »
